Olympus Corporation Clinical I entered the industry of Electronic Photographic Instruments in 2000 and has grown to employ 1 to 4 people, generating an annual revenue of $100.000 to $499.999. The NAICS classifies this business under the code 333316, which describes it as a Electronic Photographic Instruments. For further clarification, the SIC classifies this business under the code 3861 and described it as a Electronic Photographic Instruments. The business provides service to the BOTH market.
To acquire more information, please contact Hiroshi Sekiya by calling (972) 556-9697 during business hours. You can also write to the business’ Single Location at 3131 Royal Lane, Dallas, Texas TX 75229. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .
| Company: | Olympus Corporation Clinical I |
| Representative: | Hiroshi Sekiya |
| Place of Business: | 3131 Royal Lane, Dallas, TX 75229 |
| Contact Number: | (972) 556-9697 |
| Type of Service: | Electronic Photographic Instruments |
| SIC Number: | 3861 |
| NAICS Number: | 333316 |
| Locality: | Single Location |
| Market Type: | B2B & B2C |
| Began: | 2000 |
| Income/Year: | $100.000 to $499.999 |
| Laborers: | 1 to 4 |
| Share This Company: |
Olympus Corporation Clinical I is a company operating from Dallas, Texas providing professional Electronic Photographic Instruments and relevant BOTH variables. It was founded in 2000 and registered with the SIC code 3861 as Electronic Photographic Instruments, and with the NAICS code 333316 as Electronic Photographic Instruments.
With a current employee count of 1 to 4, Olympus Corporation Clinical I has gone to report making $100.000 to $499.999 per annum on its journey towards growth. This company invites you to contact its representative Hiroshi Sekiya at (972) 556-9697 for related queries, or to locate its Single Location using the coordinates 32.895365,-96.873994.
The Single Location can also be found at the street address 3131 Royal Lane in Dallas, Texas 75229 and can be engaged online through the company website at , the company Twitter , and Facebook page .